Chronic use of continuous dosing of long-term nitrates does not prevent cardiac events in patients with severe acute myocardial infarction

Cardiology

Volumn 94, Issue 3, 2000, Pages 139-145

  Kanamasa, Ken ^a   Hayashi, Takahiro ^a   Takenaka, Toshihiko ^a   Kimura, Akio ^a   Ikeda, Akiko ^a   Ishikawa, Kinji ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac events; Myocardial infarction; Nitrates; Secondary prevention; Sudden death

Indexed keywords

GLYCERYL TRINITRATE; ISOSORBIDE DINITRATE; NITRATE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SECONDARY PREVENTION; SUDDEN DEATH; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITRATES; RECURRENCE; TIME;

EID: 0034465032     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047308     Document Type: Article

References (30)

1. Role of nitrates after acute myocardial infarction
2. Oral-anti-anginal nitrates should be indicated only for single, not chronic, use in absence of long-term data, FDC cardio-renal drugs advisory CMTE concludes
3. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
5. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction
6. Correlative classification of clinical and hemodynamic function after acute myocardial infarction
7. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients
8. Cross-sectional echocardiographic analysis of the extent of left ventricular asynergy in acute myocardial infarction
9. Evaluation of a QRS scoring system for estimating myocardial infarct size. I. Specificity and observer agreement
10. Angina pectoris I. A variant form of angina pectoris. Preliminary report
11. Cardiac arrest and sudden cardiac death
12. Estimability and estimation in case-referent studies
13. The effects of oral isosorbide 5-mononitrate on mortality following acute myocardial infarction: A multicentre study
14. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials
15. Influence of long-acting nitrate therapy on the risk of reinfarction, sudden death, and total mortality in survivors of acute myocardial infarction
16. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia
17. Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies
18. Phenomenon of nitrate tolerance
19. Effects of continuous intravenous infusion of isosorbide dinitrate on development of tolerance to vasodilating action in human epicardial coronary arteries
20. Incidence of early tolerance to hemodynamic effects of continuous infusion of nitroglycerin in patients with coronary artery disease and heart failure
21. Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine
22. Coronary artery spasm after abrupt withdrawal of nitroglycerin in rabbits
23. Tolerance, rebound, and time-zero effect of nitrate therapy
24. Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta
25. 1 adrenoreceptors by nitroglycerin
26. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance
27. Antiplatelet and antithrombotic effects of organic nitrates
28. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology
29. Platelet aggregates in peripheral and coronary-sinus blood in patients with spontaneous coronary-artery spasm
30. Increased serotonin release across the coronary bed during a nonischemic interval in patients with vasospastic angina